Evidence map›Paper›PMID 33855267›Full record

ArticleJournal of the Canadian Association of Gastroenterology2021

Factors Associated with Poor Quality of Life in a Canadian Cohort of Patients with Inflammatory Bowel Disease: A Cross-sectional Study.

Amir Nazarian, Kirles Bishay, Reza Gholami, Michael A Scaffidi, Rishad Khan, Daniel Cohen-Lyons, Nadia Griller, Joshua B Satchwell, Jeffrey P Baker, Samir C Grover and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the Canadian Association of Gastroenterology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Role of Quality of Life as Endpoint for Inflammatory Bowel Disease Treatment.International journal of environmental research and public health · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Amir NazarianDivision of Gastroenterology, St. Michael's Hospital, Toronto, Ontario, Canada.
Kirles BishayDivision of Gastroenterology, St. Michael's Hospital, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0003-4478-089X
Reza GholamiDivision of Gastroenterology, St. Michael's Hospital, Toronto, Ontario, Canada.
Michael A ScaffidiDivision of Gastroenterology, St. Michael's Hospital, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0003-2068-6655
Rishad KhanDivision of Gastroenterology, St. Michael's Hospital, Toronto, Ontario, Canada.
Daniel Cohen-LyonsDivision of Gastroenterology, St. Michael's Hospital, Toronto, Ontario, Canada.
Nadia GrillerDivision of Gastroenterology, St. Michael's Hospital, Toronto, Ontario, Canada.
Joshua B SatchwellDivision of Gastroenterology, St. Michael's Hospital, Toronto, Ontario, Canada.
Jeffrey P BakerDivision of Gastroenterology, St. Michael's Hospital, Toronto, Ontario, Canada.
Samir C GroverDivision of Gastroenterology, St. Michael's Hospital, Toronto, Ontario, Canada.
Elizabeth Jan IrvineDivision of Gastroenterology, St. Michael's Hospital, Toronto, Ontario, Canada.
St. Michael's Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHealth-related quality of life (QoL) is often adversely affected in patients with inflammatory bowel disease (IBD). We aimed to identify factors associated with poor QoL among Canadian patients with IBD in clinical remission.

methodsWe enrolled patients at a single academic tertiary care center with inactive IBD. All eligible patients completed a series of questionnaires that included questions on demographics, disease activity, anxiety, depression and the presence of irritable bowel syndrome (IBS) symptoms. Stool sample for fecal calprotectin (FC) was also collected to assess for subclinical inflammation. The primary outcome measure was QoL assessed by the short inflammatory bowel disease questionnaire (SIBDQ), with planned subgroup comparisons for fatigue, anxiety, depression and IBS symptoms.

resultsNinety-three patients were eligible for inclusion in this study. The median SIBDQ scores were lower in patients with anxiety (

conclusionsAnxiety, depression, fatigue and IBS symptoms are all independently associated with lower QoL in patients with inactive IBD. Clinicians are encouraged to screen for these important factors as they may detrimentally impact QoL in IBD patients even in clinical remission.

Indexed as

Crohn’s diseaseInflammatory bowel diseaseIrritable bowel syndromeQuality of lifeUlcerative colitis

Identifiers

PMID33855267
PMCPMC8023811
OpenAlexW3042776402

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.